Literature DB >> 9494547

Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.

A G Nerlich1, I Wiest, E Wagner, U Sauer, E D Schleicher.   

Abstract

In the present study we used immunohistochemistry and in-situ hybridization for the localization of major basement membrane (BM) components and their mRNA, respectively, in order to determine the extent of BM production and deposition in normal mammary tissue as well as in invasive mamma carcinomas. While normal mammary tissue showed an intact epithelial BM, as evidenced by a continuous linear staining for collagen i.v., laminin, heparan sulfate proteoglycan (perlecan) and fibronectin, this staining was widely lost in the invasive carcinomas. Non-invasive intraductal areas of the carcinomas (carcinoma-in-situ) revealed focal fragmentation and duplication of the epithelial BM. Using in-situ hybridization, we observed only focally positive mRNA-expression for collagen i.v.-, perlecan- and fibronectin-mRNA in normal glands, while mRNA-signals were significantly enhanced in one case of fibroadenoma and particularly in invasive and non-invasive carcinomas, regardless of the degree of tumor cell differentiation. In these instances both tumor and stroma cells were positively labelled. In addition, we could demonstrate a significant increase in the level of TGF-beta 1-mRNA--as the most active cytokine for the induction of matrix component production--by carcinoma cells and to lesser extent by stroma cells. The discrepancy between significantly enhanced mRNA-synthesis and loss in protein deposition points either to an upregulated activity of matrix degrading proteinases (matrix-metalloproteinases) or a posttranslational block of protein synthesis or both.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9494547

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers.

Authors:  G Cserni; C A Wells; H Kaya; P Regitnig; A Sapino; G Floris; T Decker; M P Foschini; P J van Diest; D Grabau; A Reiner; J DeGaetano; E Chmielik; A Cordoba; X Andreu; V Zolota; E Charafe-Jauffret; A Ryska; Z Varga; N Weingertner; J P Bellocq; I Liepniece-Karele; G Callagy; J Kulka; H Bürger; P Figueiredo; J Wesseling; I Amendoeira; D Faverly; C M Quinn; S Bianchi
Journal:  Virchows Arch       Date:  2016-01-27       Impact factor: 4.064

2.  Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells.

Authors:  Keiki Nagaharu; Xinhui Zhang; Toshimichi Yoshida; Daisuke Katoh; Noriko Hanamura; Yuji Kozuka; Tomoko Ogawa; Taizo Shiraishi; Kyoko Imanaka-Yoshida
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Presence of Basement Membrane Material around the Tubules of Tubulolobular Carcinoma.

Authors:  Gábor Cserni
Journal:  Breast Care (Basel)       Date:  2008-11-25       Impact factor: 2.860

Review 4.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

Review 5.  Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk.

Authors:  Michael S Shawky; Carmela Ricciardelli; Megan Lord; John Whitelock; Vito Ferro; Kara Britt; Erik W Thompson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-12       Impact factor: 2.673

6.  Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients.

Authors:  Taha A Haj-Ahmad; Moemen Ak Abdalla; Yousef Haj-Ahmad
Journal:  J Cancer       Date:  2014-01-29       Impact factor: 4.207

Review 7.  Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan.

Authors:  Zehra Elgundi; Michael Papanicolaou; Gretel Major; Thomas R Cox; James Melrose; John M Whitelock; Brooke L Farrugia
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

Review 8.  Heparan sulfate and heparanase as modulators of breast cancer progression.

Authors:  Angélica M Gomes; Mariana P Stelling; Mauro S G Pavão
Journal:  Biomed Res Int       Date:  2013-07-31       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.